Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,056 | 80 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $416.37 | 6 | $0 (2023) |
| PFIZER INC. | $305.56 | 21 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $284.09 | 15 | $0 (2023) |
| AbbVie Inc. | $137.29 | 7 | $0 (2023) |
| Theravance Biopharma Inc. | $122.65 | 1 | $0 (2017) |
| Allergan, Inc. | $109.16 | 5 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $92.85 | 4 | $0 (2018) |
| Cumberland Pharmaceuticals, Inc. | $82.76 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $80.60 | 1 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $76.69 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $223.21 | 7 | AstraZeneca Pharmaceuticals LP ($84.67) |
| 2022 | $268.87 | 12 | ABBVIE INC. ($56.48) |
| 2021 | $122.59 | 8 | PFIZER INC. ($44.93) |
| 2020 | $171.88 | 10 | PFIZER INC. ($64.31) |
| 2019 | $509.22 | 13 | AstraZeneca Pharmaceuticals LP ($172.17) |
| 2018 | $364.24 | 13 | AstraZeneca Pharmaceuticals LP ($140.61) |
| 2017 | $396.12 | 17 | Theravance Biopharma Inc. ($122.65) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Neurology | ||||||
| 05/09/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/12/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Rare Disease | ||||||
| 03/08/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $84.67 | General |
| Category: Respiratory | ||||||
| 01/26/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/26/2022 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $30.44 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 08/15/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/16/2022 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $36.04 | General |
| Category: PULMONOLOGY | ||||||
| 06/16/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Rare Disease | ||||||
| 06/13/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: Neurology | ||||||
| 05/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/02/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/28/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/05/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/24/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Rare Disease | ||||||
| 02/18/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/01/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/22/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/19/2021 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Immunology | ||||||
| 11/10/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/25/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.92 | General |
| 07/30/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/23/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 271 | 461 | $123,864 | $34,546 |
| 2022 | 7 | 399 | 696 | $180,405 | $50,546 |
| 2021 | 6 | 408 | 674 | $187,380 | $53,635 |
| 2020 | 8 | 457 | 712 | $200,887 | $59,610 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 84 | 214 | $45,154 | $12,596 | 27.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 71 | 131 | $41,527 | $11,603 | 27.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $13,860 | $3,873 | 27.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 41 | 41 | $8,856 | $2,455 | 27.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 28 | 28 | $8,568 | $2,377 | 27.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $5,899 | $1,642 | 27.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 128 | 315 | $84,105 | $23,795 | 28.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 87 | 193 | $35,898 | $9,964 | 27.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 63 | 63 | $32,571 | $9,183 | 28.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 52 | 52 | $14,300 | $3,811 | 26.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 42 | 42 | $7,854 | $2,234 | 28.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 16 | 16 | $2,992 | $796.29 | 26.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 11 | 15 | $2,685 | $762.96 | 28.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 146 | 338 | $90,052 | $26,113 | 29.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 65 | 65 | $33,561 | $9,268 | 27.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 71 | 139 | $25,762 | $7,359 | 28.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 72 | 74 | $20,287 | $5,936 | 29.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 14 | 18 | $10,244 | $2,781 | 27.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 40 | 40 | $7,474 | $2,176 | 29.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 154 | 340 | $90,088 | $26,947 | 29.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 80 | 81 | $41,639 | $12,257 | 29.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 78 | 141 | $25,949 | $7,553 | 29.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 57 | 58 | $15,776 | $4,620 | 29.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 15 | 19 | $10,754 | $3,235 | 30.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 40 | 40 | $7,440 | $2,233 | 30.0% |
About Dr. Thomas Worley, MD
Dr. Thomas Worley, MD is a Internal Medicine healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013944545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Worley, MD has received a total of $2,056 in payments from pharmaceutical and medical device companies, with $223.21 received in 2023. These payments were reported across 80 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,056).
As a Medicare-enrolled provider, Worley has provided services to 1,535 Medicare beneficiaries, totaling 2,543 services with total Medicare billing of $198,337. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Knoxville, TN
- Active Since 06/28/2006
- Last Updated 05/09/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1013944545
Products in Payments
- XARELTO (Drug) $284.09
- ELIQUIS (Drug) $259.99
- FASENRA (Drug) $214.23
- DALVANCE (Drug) $186.38
- CHANTIX (Drug) $90.49
- FASENRA (Biological) $84.67
- Caldolor (Drug) $82.76
- COMBIVENT RESPIMAT (Drug) $80.60
- LOKELMA (Drug) $67.89
- ULTOMIRIS (Biological) $60.62
- Briviact (Drug) $56.05
- ENTRESTO (Drug) $45.23
- TEFLARO (Drug) $44.17
- ANDEXXA (Biological) $36.04
- CHARTIS CATHETER (Device) $36.04
- BRILINTA (Drug) $30.66
- Kcentra (Biological) $30.44
- Astral (Device) $23.46
- SAMSCA (Drug) $19.04
- LANTUS (Drug) $18.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Knoxville
Ross Nesbit, Md, MD
Internal Medicine — Payments: $432,287
Dr. Dennis Deruelle, Md, Fhm, MD, FHM
Internal Medicine — Payments: $289,726
Ayaz Rahman, M.d, M.D
Internal Medicine — Payments: $250,855
Dr. David Chism, Md, MD
Internal Medicine — Payments: $47,436
Morgan Randall
Internal Medicine — Payments: $45,633
Kimberly Morris, Md, MD
Internal Medicine — Payments: $32,540